Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: Single-Center experience from China (Cai Y et al. Int J Hematol, January 2021)

Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: Single-Center experience from China
Cai Y et al. Int J Hematol, January 2021 (epub ahead of print)

Link to full abstract

 


 

Successful haploidentical stem cell transplant with posttransplant cyclophosphamide for isolated central nervous system blast crisis in a child with CML (Chatterjee G et al. J Pediatr Hematol Oncol, January 2021)

Successful haploidentical stem cell transplant with posttransplant cyclophosphamide for isolated central nervous system blast crisis in a child with CML
Chatterjee G et al. J Pediatr Hematol Oncol, January 2021

Link to full abstract

 


 

Lymphoblastic predominance of blastic phase in children with chronic myeloid leukemia treated with imatinib: A report from the I-CML-Ped Study (Meyran D et al. Eur J Cancer, August 2020)

Lymphoblastic predominance of blastic phase in children with chronic myeloid leukemia treated with imatinib: A report from the I-CML-Ped Study
Meyran D et al. Eur J Cancer, August 2020 (epub ahead of print)

Link to full abstract

 


 

Factors and outcomes of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry (Meral Günes A et al. Pediatr Blood Cancer, October 2020)

Factors and outcomes of chronic myeloid leukemia at very young age: Data from the International Pediatric Chronic Myeloid Leukemia Registry
Meral Günes A et al. Pediatr Blood Cancer, October 2020

Link to full abstract

 


 

A case of childhood blastic phase chronic myeloid leukemia with minor BCR-ABL (Yamanaka J et al. J Pediatr Hematol Oncol, August 2020)

A case of childhood blastic phase chronic myeloid leukemia with minor BCR-ABL
Yamanaka J et al. J Pediatr Hematol Oncol, August 2020

Link to full abstract

 


 

  1. Pediatric chronic myeloid leukemia with myeloid blast crisis and complex karyotype at presentation (Sazawal S et al. Indian J Cancer, July - Sept 2020)
  2. Outcomes of children with chronic myeloid leukemia: A population-based cohort study (Egan G et al. Pediatr Blood Cancer, July 2020)
  3. Sustained molecular response following a failed attempt of tyrosine kinase inhibitor discontinuation and the effects on growth in a child with CML: not always a short story (Triche L et al. Pediatr Hematol, Oncol, August 2020)
  4. BCR-ABL tyrosine kinase inhibitors in the treatment of pediatric CML (Carafiglio F et al. Int J Mol Sci, June 2020)